Reveal LINQ™ Insertable Cardiac Monitor (ICM)
The Reveal LINQ™ ICM system is ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management. The Reveal LINQ™ ICM is simple, yet dramatically smaller and more accurate than any other insertable cardiac monitor.1-8 The video below illustrates the minimally invasive, intuitive insertion procedure which requires minimal procedure time and clinical resources.
- World’s smallest ICM: one-third the size of an AAA battery (1.2 cc)
- Up to 3-year longevity for long-term monitoring9
- MR Conditional at 1.5 and 3.0 Tesla
- Minimally invasive with simplified insertion procedure
- Highest published AF detection accuracy at 99.4%10
- Most clinically validated ICM with 50+ detection performance papers11
- 500+ published clinical articles and abstracts12
- Most clinically-validated ICM across cryptogenic stroke, syncope and atrial fibrillation patient populations1, 3, 10
- Only ICM with evidence published in multiple premier journals including Heart Rhythm, NEJM, JACC1,6, 10
TruRhythm Detection inside Reveal LINQ ICM
- A new second sensing filter that analyzes rhythms for possible undersensing in brady and pause
- A fifth-generation atrial fibrillation algorithm that learns and adapts to the patient’s rhythm over time
- 54% reduction in false detections*13
- Streamlined episode review and reporting
* Compared with Reveal LINQ™ ICM without TruRhythm™ Detection
- Sanna T, Diener HC, Passman RS, et al. Cryptogenic Stroke and Underlying Atrial Fibrillation (CRYSTAL AF). N Engl J Med. June 26, 2014;370(26):2478-2486.
- Purerfellner H, Pokushalov E, Sarkar S, et al. P-wave evidence as a method for improving algorithm to detect atrial fibrillation in insertable cardiac monitors. Heart Rhythm. September 2014;11(9):1575-1583.
- Edvardsson N, Frykman V, van Mechelin R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. February 2011;13(2):262-269.
- Krahn AD, Klein GJ, Yee R, Norris C. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol. July 1, 1998;82(1):117-119.
- Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation. January 26, 1999;99(3):406-410.
- Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol. August 6, 2003;42(3):495-501.
Sanders P, Pürerfellner H, Pokushalov E, et al. Performance of a New Atrial Fibrillation Detection Algorithm in a Miniaturized ICM: Results from the Reveal LINQ Usability Study. Heart Rhythm. Published online March 4, 2016.
Medtronic data on file, 2014.
Reference the Reveal LINQ ICM Clinician Manual for usage parameters.
Sanders P, Pürerfellner H, Pokushalov E, et al. Performance of a New Atrial Fibrillation Detection Algorithm in a Miniaturized ICM: Results from the Reveal LINQ Usability Study. Heart Rhythm. Published online March 4, 2016. Accessed online April 6, 2016 at http://www.heartrhythmjournal.com/article/S1547-5271(16)30006-6/fulltext.
Medtronic Reveal AF Publications. Medtronic data on file. 2016.
Medtronic Reveal Publications. Medtronic data on file. 2016.
TruRhythm™ Detection Algorithms. Medtronic data on file. 2017.